Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2014 from OUS - Intracellular transport (Sandvig)

12 publications found

Asp N, Pust S, Sandvig K (2014)
Flotillin depletion affects ErbB protein levels in different human breast cancer cells
Biochim Biophys Acta, 1843 (9), 1987-96
DOI 10.1016/j.bbamcr.2014.04.013, PubMed 24747692

Bergan J, Skotland T, Lingelem AB, Simm R, Spilsberg B, Lindbäck T, Sylvänne T, Simolin H, Ekroos K, Sandvig K (2014)
The ether lipid precursor hexadecylglycerol protects against Shiga toxins
Cell Mol Life Sci, 71 (21), 4285-300
DOI 10.1007/s00018-014-1624-1, PubMed 24740796

Cordara G, Winter HC, Goldstein IJ, Krengel U, Sandvig K (2014)
The fungal chimerolectin MOA inhibits protein and DNA synthesis in NIH/3T3 cells and may induce BAX-mediated apoptosis
Biochem Biophys Res Commun, 447 (4), 586-9
DOI 10.1016/j.bbrc.2014.04.043, PubMed 24747075

Holland P, Torgersen ML, Sandvig K, Simonsen A (2014)
LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis
Traffic, 15 (12), 1390-405
DOI 10.1111/tra.12227, PubMed 25216107

Kvalvaag AS, Pust S, Sandvig K (2014)
Vps11, a subunit of the tethering complexes HOPS and CORVET, is involved in regulation of glycolipid degradation and retrograde toxin transport
Commun Integr Biol, 7 (1), e28129
DOI 10.4161/cib.28129, PubMed 24778763

Phuyal S, Hessvik NP, Skotland T, Sandvig K, Llorente A (2014)
Regulation of exosome release by glycosphingolipids and flotillins
FEBS J, 281 (9), 2214-27
DOI 10.1111/febs.12775, PubMed 24605801

Phuyal S, Skotland T, Hessvik NP, Simolin H, Øverbye A, Brech A, Parton RG, Ekroos K, Sandvig K, Llorente A (2014)
The ether lipid precursor hexadecylglycerol stimulates the release and changes the composition of exosomes derived from PC-3 cells
J Biol Chem, 290 (7), 4225-37
DOI 10.1074/jbc.M114.593962, PubMed 25519911

Sandvig K, Bergan J, Kavaliauskiene S, Skotland T (2014)
Lipid requirements for entry of protein toxins into cells
Prog Lipid Res, 54, 1-13
DOI 10.1016/j.plipres.2014.01.001, PubMed 24462587

Simm R, Ahmad I, Rhen M, Le Guyon S, Römling U (2014)
Regulation of biofilm formation in Salmonella enterica serovar Typhimurium
Future Microbiol, 9 (11), 1261-82
DOI 10.2217/fmb.14.88, PubMed 25437188

Słomińska-Wojewódzka M, Pawlik A, Sokołowska I, Antoniewicz J, Węgrzyn G, Sandvig K (2014)
The role of EDEM2 compared with EDEM1 in ricin transport from the endoplasmic reticulum to the cytosol
Biochem J, 457 (3), 485-96
DOI 10.1042/BJ20130155, PubMed 24200403

Solhaug A, Torgersen ML, Holme JA, Lagadic-Gossmann D, Eriksen GS (2014)
Autophagy and senescence, stress responses induced by the DNA-damaging mycotoxin alternariol
Toxicology, 326, 119-29
DOI 10.1016/j.tox.2014.10.009, PubMed 25456271

Yermakova A, Klokk TI, Cole R, Sandvig K, Mantis NJ (2014)
Antibody-mediated inhibition of ricin toxin retrograde transport
MBio, 5 (2), e00995
DOI 10.1128/mBio.00995-13, PubMed 24713323

 
Page visits: 72968